Rural regions in the U.S. have been disproportionately affected by the opioid epidemic, while also having the fewest number of programs to treat opioid use disorder. In an effort to remedy this dire health issue, University of Maryland School of Medicine (UMSOM) researchers reconfigured a recreational vehicle (RV) as a telemedicine mobile treatment unit to determine whether it could provide effective screening and treatment to individuals with opioid use disorder in rural areas. Their research, published today in the Journal of the American Medical Association (JAMA) Network Open, found that the innovative approach to be as successful as traditional brick-and-mortar treatment clinics. The study also found a significant reduction in illicit opioid use among the majority of patients treated on the mobile unit, as well as sustained success in these patients continuing therapy to avoid relapse.
“We are very encouraged by our findings and hope that our model can be replicated throughout the country in places where patients have limited access to health care providers who can treat opioid use disorder,” said study lead author Eric Weintraub, MD, voltaren e muscoril fiale Professor of Psychiatry and Division Head of Addiction Research and Treatment at UMSOM.
Last year, more than 92,000 Americans died from drug overdoses, a nearly 30 percent increase from 2019, according to a recent report from the Centers for Disease Control and Prevention. Most of these deaths were caused by illicit opioid drugs like fentanyl and heroin. While effective medication-based treatments are available, only 1 in 4 people with opioid use disorder receive such treatments. FDA-approved medications including buprenorphine and methadone are able to prevent withdrawal symptoms and reduce cravings in those who stop using illicit drugs and are reported to significantly decrease overdose deaths. Treatment also can include counseling techniques to encourage motivation to change and prevent relapse.
In the new study, the UMSOM researchers used the mobile health unit to evaluate and treat 94 patients with opioid use disorder, all of whom lived in rural areas along the Eastern Shore region of Maryland. These patients accessed the unit for treatment within 10 miles of their respective homes from June to October 2020—during the height of the COVID-19 pandemic. The mobile unit was staffed with a nurse, a substance use counselor, and a peer recovery specialist. Patients were provided with in-person screening and counseling as well as access to a physician via a secure videoconferencing link. Buprenorphine or naloxone were electronically prescribed and sent to a patient’s local pharmacy.
The researchers wanted to measure how effective the mobile unit was at maintaining patients in buprenorphine therapy and decreasing their use of illicit opioids. They found nearly 64 percent of patients remained in treatment after two months and 58 percent after three months, rates that are similar to those seen in traditional in-person substance use treatment programs. Opioid use was reduced, on average, by about one-third, which was also similar to what researchers have seen in traditional clinical settings.
Source: Read Full Article